Zobrazeno 1 - 10
of 140
pro vyhledávání: '"R. Bolus"'
Autor:
Kristin R, Peterson, Dario A, Gutierrez, Takuya, Kikuchi, Emily K, Anderson-Baucum, Nathan C, Winn, Megan M, Shuey, William R, Bolus, Owen P, McGuinness, Alyssa H, Hasty
Publikováno v:
Am J Physiol Endocrinol Metab
Given the chemoattractant potential of complement factor 5 (C5) and its increased expression in adipose tissue (AT) of obese mice, we determined whether this protein of the innate immune system impacts insulin action. C5 control (C5(cont)) and sponta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f416209c8d6a6eff578ec18ebe2b3545
https://pubmed.ncbi.nlm.nih.gov/31084499
https://pubmed.ncbi.nlm.nih.gov/31084499
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The Journal of small animal practice. 52(7)
Objectives: To investigate risk factors associated with cranial cruciate ligament rupture in dogs. Methods: Retrospective case-control study: medical records of a first-opinion veterinary practice were searched for dogs diagnosed with cranial cruciat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a75b728a568ec4561b1e2729bf3f96e0
https://pubmed.ncbi.nlm.nih.gov/21651558
https://pubmed.ncbi.nlm.nih.gov/21651558
Autor:
B M R, Spiegel, R, Bolus, N, Agarwal, G, Sayuk, L A, Harris, S, Lucak, E, Esrailian, W D, Chey, A, Lembo, H, Karsan, K, Tillisch, J, Talley, L, Chang
Publikováno v:
Alimentary pharmacologytherapeutics. 32(10)
There is uncertainty about how to measure patient-reported outcomes (PROs) in IBS. The Food and Drug Administration (FDA) emphasizes that PROs must be couched in a conceptual framework, yet existing IBS PROs were not based on such a framework.To perf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90430444986b1dd35bc99bde7c44be2d
https://pubmed.ncbi.nlm.nih.gov/20955447
https://pubmed.ncbi.nlm.nih.gov/20955447
Autor:
B M R, Spiegel, R, Bolus, L A, Harris, S, Lucak, W D, Chey, G, Sayuk, E, Esrailian, A, Lembo, H, Karsan, K, Tillisch, J, Talley, L, Chang
Publikováno v:
Alimentary pharmacologytherapeutics. 32(9)
Although irritable bowel syndrome (IBS) is a multisymptom disorder, abdominal pain drives illness severity more than other symptoms. Despite consensus that IBS trials should measure pain to define study entry and determine efficacy, the optimal metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::946183fabc3d74db5bfce2c01a2ebb1f
https://pubmed.ncbi.nlm.nih.gov/20807217
https://pubmed.ncbi.nlm.nih.gov/20807217
Publikováno v:
Alimentary pharmacologytherapeutics. 20(1)
Anxiety related to gastrointestinal sensations, symptoms or the contexts in which these may occur is thought to play a significant role in the pathophysiology as well as in the health outcomes of patients with irritable bowel syndrome.To develop a va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1abb4c709d12b2f04f4b5c79382d96ec
https://pubmed.ncbi.nlm.nih.gov/15225175
https://pubmed.ncbi.nlm.nih.gov/15225175
Publikováno v:
Managed care (Langhorne, Pa.). 8(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::58f46362157af68a7cb78ae3e47bb629
https://pubmed.ncbi.nlm.nih.gov/10387373
https://pubmed.ncbi.nlm.nih.gov/10387373
Publikováno v:
Stroke. 21:1280-1282
Although the development and use of severity-of-illness measures has gained widespread enthusiasm, uncertainty remains as to the optimal measure for stroke patients. The Health Care Financing Administration recently derived a severity-of-illness meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca439e048bd2b38b339fa898b12501ad
https://doi.org/10.1161/01.str.21.9.1280
https://doi.org/10.1161/01.str.21.9.1280